|4Jan 11, 6:44 PM ET

Hansard Adam 4

4 · Applied Therapeutics Inc. · Filed Jan 11, 2022

Insider Transaction Report

Form 4
Period: 2022-01-07
Hansard Adam
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2022-01-07+31,70096,970 total
  • Award

    Employee Stock Option (Right to Buy)

    2022-01-07+21,10021,100 total
    Exercise: $4.17Exp: 2032-01-07Common Stock (21,100 underlying)
Footnotes (2)
  • [F1]Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 7, 2023, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.
  • [F2]Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION